Regulation of survivin by PI3K/Akt/p70S6K1 pathway

Biochemical and Biophysical Research Communications

Volumn 395, Issue 2, 2010, Pages 219-224

  Zhao, Peng ^a   Meng, Qiao ^b   Liu, Ling Zhi ^b   You, You Ping ^a   Liu, Ning ^a   Jiang, Bing Hua ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Akt; CEF; p70S6K1; PI3K; siRNA; Survivin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; MESSENGER RNA; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN P70S6K1; RAPAMYCIN; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CHICK EMBRYO; CHROMONES; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; NEOPLASMS; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; RNA, SMALL INTERFERING; SIROLIMUS;

EID: 77951623315     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.165     Document Type: Article

References (36)

1. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
2. Scott F.L., Denault J.B., Riedl S.J., Shin H., Renatus M., and Salvesen G.S. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J. 24 (2005) 645-655
3. Salvesen G.S., and Duckett C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3 (2002) 401-410
4. Mita A.C., Mita M.M., Nawrocki S.T., and Giles F.J. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin. Cancer Res. 14 (2008) 5000-5005
5. Bilancio A., Okkenhaug K., Camps M., Emery J.L., Ruckle T., Rommel C., and Vanhaesebroeck B. Key role the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis genetic and pharmacologic interference with p110delta function in B cells. Blood 107 (2006) 642-650
6. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., and Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40 (2001) 1117-1123
7. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
8. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22 (2003) 8581-8589
9. Papapetropoulos A., Fulton D., Mahboubi K., Kalb R.G., O'Connor D.S., Li F., Altieri D.C., and Sessa W.C. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275 (2000) 9102-9105
10. Tran J., Rak J., Sheehan C., Saibil S.D., LaCasse E., Korneluk R.G., and Kerbel R.S. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 264 (1999) 781-788
11. Asanuma H., Torigoe T., Kamiguchi K., Hirohashi Y., Ohmura T., Hirata K., Sato M., and Sato N. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 65 (2005) 11018-11025
12. Carter B.Z., Milella M., Altieri D.C., and Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 97 (2001) 2784-2790
13. Beierle E.A., Nagaram A., Dai W., Iyengar M., and Chen M.K. VEGF-mediated survivin expression in neuroblastoma cells. J. Surg. Res. 127 (2005) 21-28
14. Kim S., Kang J., Qiao J., Thomas R.P., Evers B.M., and Chung D.H. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas. J. Pediatr. Surg. 39 (2004) 516-521
15. Dan H.C., Jiang K., Coppola D., Hamilton A., Nicosia S.V., Sebti S.M., and Cheng J.Q. Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis. Oncogene 23 (2004) 706-715
16. Omura G.A. Progress in gynecologic cancer research: the Gynecologic Oncology Group experience. Semin. Oncol. 35 (2008) 507-521
17. Lu J., Tan M., Huang W.C., Li P., Guo H., Tseng L.M., Su X.H., Yang W.T., Treekitkarnmongkol W., Andreeff M., Symmans F., and Yu D. Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to taxol resistance. Clin. Cancer Res. 15 (2009) 1326-1334
18. Zhou J., O'brate A., Zelnak A., and Giannakakou P. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol. Cancer Res. 64 (2004) 8708-8714
19. Cheung C.H., Chen H.H., Kuo C.C., Chang C.Y., Coumar M.S., Hsieh H.P., and Chang J.Y. Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers. Mol. Cancer 8 (2009) 43
20. Liu L.Z., Hu X.W., Xia C., He J., Zhou Q., Shi X., Fang J., and Jiang B.H. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med 41 (2006) 1521-1533
21. Xia C., Meng Q., Liu L.Z., Rojanasakul Y., Wang X.R., and Jiang B.H. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 67 (2007) 10823-10830
22. Meng Q., Xia C., Fang J., Rojanasakul Y., and Jiang B.H. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal. 18 (2006) 2262-2271
23. Komuro Y., Watanabe T., Tsurita G., Muto T., and Nagawa H. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis. Mod. Pathol. 17 (2004) 264
24. Aoki M., Batista O., Bellacosa A., Tsichlis P., and Vogt P.K. The akt kinase: molecular determinants of oncogenicity. Proc. Natl. Acad. Sci. USA 95 (1998) 14950-14955
25. Chang H.W., Aoki M., Fruman D., Auger K.R., Bellacosa A., Tsichlis P.N., Cantley L.C., Roberts T.M., and Vogt P.K. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276 (1997) 1848-1850
26. Jiang B.H., Aoki M., Zheng J.Z., Li J., and Vogt P.K. Myogenic signaling of phosphatidylinositol 3-kinaserequires the serine-threonine kinase Akt/protein kinase B. Proc. Natl. Acad. Sci. USA 96 (1999) 2077-2081
27. Jiang B.H., Zheng J.Z., and Vogt P.K. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proc. Natl. Acad. Sci. USA 95 (1998) 14179-14183
28. Faivre S., Kroemer G., and Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 5 (2006) 671-688
29. Ling X., Bernacki R.J., Brattain M.G., and Li F. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. J. Biol. Chem. 279 (2004) 15196-15203
30. Zaffaroni N., Pennati M., Colella G., Perego P., Supino R., Gatti L., Pilotti S., Zunino F., and Daidone M.G. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer. Cell Mol. Life Sci. 59 (2002) 1406-1412
31. Harfouche R., Hassessian H.M., Guo Y., Faivre V., Srikant C.B., Yancopoulos G.D., and Hussain S.N. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells. Microvasc. Res. 64 (2002) 135-147
32. Mesri M., Morales-Ruiz M., Ackermann E.J., Bennett C.F., Pober J.S., Sessa W.C., and Altieri D.C. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am. J. Pathol. 158 (2001) 1757-1765
33. O'Connor D.S., Schechner J.S., Adida C., Mesri M., Rothermel A.L., Li F., Nath A.K., Pober J.S., and Altieri D.C. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156 (2000) 393-398
34. Tran J., Master Z., Yu J.L., Rak J., Dumont D.J., and Kerbel R.S. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad. Sci. USA 99 (2002) 4349-4354
35. Asanuma K., Kobayashi D., Furuya D., Tsuji N., Yagihashi A., and Watanabe N. A role for survivin in radioresistance of pancreatic cancer cells. Jpn. J. Cancer Res. 93 (2002) 1057-1062
36. O'Connor D.S., Wall N.R., Porter A.C., and Altieri D.C. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2 (2002) 43-54